The Clinical Utility of FDG PET-CT in Evaluation of Bone Marrow Involvement by Lymphoma-Reference-Cited by-同舟云学术

The Clinical Utility of FDG PET-CT in Evaluation of Bone Marrow Involvement by Lymphoma

Published:2014-11-24 Issue:3 Volume:47 Page:458-464
ISSN:1598-2998
Container-title:Cancer Research and Treatment
language:en
Short-container-title:Cancer Res Treat

Author:

Kim Ho Young,Kim Ju-Seok,Choi Dae Ro,Kim Hyeong Su,Kwon Jung Hye,Jang Geun-Doo,Kim Jung Han,Jung Joo Young,Song Hun Ho,Lee Young Kyung,Min Soo Kee,Hwang Hee Sung,Kim Hwa Jung,Zang Dae Young,Kim Hyo Jung

Publisher

Korean Cancer Association

Subject

Cancer Research,Oncology

Link

http://e-crt.org/upload/pdf/crt-2014-091.pdf

Reference25 articles.

1. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of Hodgkin's disease

2. Minimum Clinical Recommendations for diagnosis, treatment and follow-up of newly diagnosed follicular lymphoma

3. Bone Marrow Involvement by Hodgkin and Non-Hodgkin Lymphomas

4. Value of bilateral bone marrow biopsy specimens in non-Hodgkin's lymphoma.

5. Clinical outcome of low-grade NHL patients with bone marrow involvement

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FDG PET/CT versus Bone Marrow Biopsy for Diagnosis of Bone Marrow Involvement in Non-Hodgkin Lymphoma: A Systematic Review;Applied Sciences;2022-01-06

2. Performance of Positron Emission Tomography-Computed Tomography and Bone Marrow Biopsy in Detecting Bone Marrow Infiltration in Lymphoma Cases;Turkish Journal of Hematology;2020-11-19

3. Comparison of the RECIST and EORTC PET criteria in the tumor response assessment: a pooled analysis and review;Cancer Chemotherapy and Pharmacology;2017-08-05

4. Comparison of the RECIST and PERCIST criteria in solid tumors: a pooled analysis and review;Oncotarget;2016-03-28